Orladeyo 150 mg
Orladeyo 150 mg is a medicine authorised by Swissmedic under authorisation number 68464. The authorisation holder is BioCryst Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 June 2022 and the authorisation is limited until 06 June 2027. ATC code B06AC06 places the medicine in the group Other hematological agents.
| Authorisation number | 68464 |
|---|---|
| Name | Orladeyo 150 mg |
| Full name | Orladeyo 150 mg, Hartkapseln |
| Authorisation holder | BioCryst Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B06AC06 |
| First authorisation | 07 June 2022 |
| Authorisation validity | 06 June 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Orladeyo 150 mg, Hartkapseln | B | 07 June 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Hartkapseln | B06AC06 | 02.99.0. | B |
Scroll the table sideways
Frequently asked questions
Is Orladeyo 150 mg authorised in Switzerland?
Yes. Orladeyo 150 mg is authorised by Swissmedic under authorisation number 68464, data as of 01 September 2026. The authorisation is limited until 06 June 2027.
Which dispensing category does Orladeyo 150 mg have?
Orladeyo 150 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Orladeyo 150 mg?
The authorisation holder is BioCryst Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.